# VENTILATION-FREE DAYS TO ESTIMATE THE BENEFIT OFCORTICOTHERAPY FOR THE TREATMENT OFCOMMUNITY ACQUIRED PNEUMONIA IN HOSPITALIZED PATIENTS

The main objective of this project is to reanalyze. a clinical trial in order to evaluate the effect of corticosteroids on clinical outcomes in patients with severe CAP, with particular attention to ventilation free days (VFDs), a novel outcome introduced in the present analysis.

## Data

Data is a double blind randomized clinical trial with 120 patients enrolled and followed up across three Spanish hospitals from June 2004
through February 2012. 90 patients are admitted in the ICU and are the target for the analysis on VFDs.

## Effect of corticosteroids on VFDs 
- 
$$
\text{VFDs} =
\begin{cases}
  0, \text{  if patients died or stayed longer than 28 days in the ICU} \\ 
  28 - \text{number of days in the ICU}, \text{otherwise}
\end{cases}
$$

- X: the random variable representing the treatment group (1 for treatment), $X \in \{0,1\}$
- Y: the random variable to explain, representing the number of VFDs , $Y \in \llbracket0,28\rrbracket$
- Z the variable which indicates if the patient died (in-hospital death at 28 days, 1 for death), $ Z \in \{0,1\}$.
X,Y and Z are not independent.

$$
\begin{cases}
Y \mid Z = 0, X=x  \sim \mathcal{NB}(\mu_{x},\theta), x \in \{0,1\} \\
Y \mid Z=1, X=x \sim \mathcal{B}(\pi(x))  \text{ (Bernoulli distribution)}
\end{cases}
$$

where:
- $\pi(x)= P(Z=1 \mid X=x)= \frac{\exp(\alpha_0 + \alpha_1 x)}{1 + \exp(\alpha_0 + \alpha_1 x)} \cdot \mathbf{1}_{x \in \{0,1\}}$ is the probability of dying considering the treatment group, modeled using a logistic regression. $\alpha_0$ is affiliated with the proportion of death for placebo group, and $\alpha_1$, with the effect of the treatment on the proportion of death.
- $\mu_{x} = \exp(\beta_0 + \beta_1 x)$ is the average number of VFDs, which is considered dependent on the treatment group. $\beta_0$ is affiliated with the average number of VFDs for placebo group, and $\beta_1$, the effect of the treatment on VFDs.
\end{itemize}

**Frequentist approach**

Zero-inflated model:

$$
\boxed{
f_{Y \mid X,Z}(y\mid x,z)= 
\begin{cases}
\Biggl[\pi(x) + (1-\pi(x))\left(\frac{\theta}{\theta + \mu_{x}}\right)^{\theta}\Biggl]\cdot \mathbf{1}_{\{\mu_{x} > 0, \theta > 0\}} \cdot \mathbf{1}_{x \in \{0,1\}} , & \text{if y=0}    \\
(1-\pi(x))\frac{\Gamma(y + \theta)}{y! \ \Gamma(\theta)} \left(\frac{\theta}{\theta + \mu_{x}}\right)^{\theta} \left(\frac{\mu_{x}}{\theta + \mu_{x}}\right)^y \cdot \mathbf{1}_{\mathbb{N}}(y) \cdot \mathbf{1}_{\{\mu_{x} > 0, \theta > 0\}} \cdot \mathbf{1}_{x \in \{0,1\}}, & \text{if y>0}
\end{cases}
}
$$  

Parameters are estimated by maximazign log-likelihood

**Bayesian approach**

$$
\scriptsize
\boxed{
\psi(\alpha, \beta, \theta \mid y)\approx \theta^{a-1}\frac{b^a e^{-b\theta}}{\Gamma(a)} \frac{exp(-\frac{1}{2}((\alpha,\beta)-\mu)^\top\Sigma^-1((\alpha,\beta)-\mu))}{2\pi^2|\Sigma|^\frac{1}{2}}\Biggl [ \pi(x) \mathbf{1}_{y=0}+
\\
(1-\pi(x))\binom{y+\theta-1}{y}p(x)^{\theta}(1-p(x))^y \Biggr]
}
$$


## References

- Torres, Antoni, et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial. *JAMA* 313.7 (2015): 677-686. https://doi.org/10.1001/jama.2015.88

## Requirements
- Install JAGS at http://www.sourceforge.net/projects/mcmc-jags/files
- "main_ITT.ipynb" is the analysis in intention-to-treat and "main_PP.ipynb" is the exact same but for per-protocol population.